Sign in
4

Changes in Ownership

PTC THERAPEUTICS, INC. Filed Acc 0001415889-25-022309

EXEC. VP AND CLO sold 2,813 shares at $48.58 ($136,656)

  • EXEC. VP AND CLO acquired 2,813 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Boulding Mark Elliott EXEC. VP AND CLO 2025-08-15 Option exercise 10b5-1 +2,813 $25.69 $72,266 106,714 D
Boulding Mark Elliott EXEC. VP AND CLO 2025-08-15 Sale 10b5-1 −2,813 $48.58 $136,656 103,901 D
Derivatives
Boulding Mark Elliott EXEC. VP AND CLO 2025-08-15 Option exercise · Stock Option (Right to Buy) 10b5-1 −2,813 24,899 D
Open-market sales · 2,813 sh · avg $48.58 · $136,656
Loading xslF345X05/form4-08192025_040801.xml…